Fig. 1: S100A11 expression is upregulated and predicts poor prognosis of patients with PDAC. | Cell Death & Disease

Fig. 1: S100A11 expression is upregulated and predicts poor prognosis of patients with PDAC.

From: S100A11 activates the pentose phosphate pathway to induce malignant biological behaviour of pancreatic ductal adenocarcinoma

Fig. 1

A Analysis of S100A11 protein expression in PDAC and paracancerous tissues through IHC-based TMA (inset: 20× magnified image). B, D Violin plots demonstrating the difference in S100A11 expression between PDAC and paired paracancerous samples in the TMA cohort and TCGA database, respectively. C, E Kaplan–Meier analyses of the association between S100A11 expression and OS of PDAC from the TMA cohort and TCGA database, respectively. F Correlation analysis between the S100A11 expression and clinicopathological characteristics using online TCGA case cohort. G, H Univariate and multivariate Cox regression analyses of the relationship between the expression of S100A11 and clinicopathological factors with TCGA database. T, pancreatic cancer tissues. NT, normal paracancerous tissues. *p < 0.05.

Back to article page